Looks to me like the sell-off is over done. Seems to be caught up in the general negative sentiment of healthcare at the moment (off the back of the poor Healthscope result). Not sure that really has anything to do with MYX and the operations in the states... Should represent a good buying opportunity.
The only other things could be poor integration of the acquired drugs (unlikely, purchased at PE 6x!) could be Hillary's negative statements about pharma's... but as another poster pointed out, that seems to be aimed at the shonky operators.
Back of the envelope and reasonably conservative calcs for me says this is trading at about PE 15, cheap for healthcare and certainly cheap for a growth company like MYX.
MYX Price at posting:
$1.75 Sentiment: Buy Disclosure: Held
